Literature DB >> 12021868

Novel peptides that inhibit the propagation of Newcastle disease virus.

P Ramanujam1, W S Tan, S Nathan, K Yusoff.   

Abstract

A disulfide constrained random heptapeptide library displayed on filamentous bacteriophage M13 was applied to select specific ligands that interact with Newcastle disease virus (NDV). A fusion phage carrying the amino acid sequence TLTTKLY was selected from the panning procedure. An antibody competition assay showed that the selected phage was capable of competing with the polyclonal antibodies raised against NDV for binding sites on the virus. Determination of the binding affinity of this phage with NDV by an equilibrium binding assay in solution revealed two different dissociation constants, suggesting that there could be two distinct binding sites for the phage on NDV. Synthetic peptides with the sequence CTLTTKLYC, either in linear or cyclic conformations inhibited the binding of phage bearing the same sequence to NDV. These peptides also inhibited the hemolytic activity of the virus as well as its propagation in embryonated chicken eggs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021868     DOI: 10.1007/s00705-001-0778-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Selection of antiviral peptides against mink enteritis virus using a phage display Peptide library.

Authors:  Qingming Zhang; Yuping Wang; Qun Ji; Jingmin Gu; Shanshan Liu; Xin Feng; Changjiang Sun; Yingying Li; Liancheng Lei
Journal:  Curr Microbiol       Date:  2012-12-13       Impact factor: 2.188

2.  Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.

Authors:  Mohamed Rajik; Fatemeh Jahanshiri; Abdul Rahman Omar; Aini Ideris; Sharifah Syed Hassan; Khatijah Yusoff
Journal:  Virol J       Date:  2009-06-05       Impact factor: 4.099

3.  Selection of peptides that target the aminoacyl-tRNA site of bacterial 16S ribosomal RNA.

Authors:  Mei Li; Anne-Cécile E Duc; Edvin Klosi; Srividya Pattabiraman; Mark R Spaller; Christine S Chow
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

4.  Mimotopes of the Vi antigen of Salmonella enterica serovar typhi identified from phage display peptide library.

Authors:  Swee-Seong Tang; Wen-Siang Tan; Shamala Devi; Lin-Fa Wang; Tikki Pang; Kwai-Lin Thong
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

5.  An overview on the development of newcastle disease virus as an anti-cancer therapy.

Authors:  Abdul Rahman Omar; Aini Ideris; Abdul Manaf Ali; Fauziah Othman; Khatijah Yusoff; Jafri Malin Abdullah; Haryati Shila Mohamad Wali; Madihah Zawawi; Narayani Meyyappan
Journal:  Malays J Med Sci       Date:  2003-01

6.  Characterization of Malaysian velogenic NDV strain AF2240-I genomic sequence: a comparative study.

Authors:  Kavitha Murulitharan; Khatijah Yusoff; Abdul Rahman Omar; Aidin Molouki
Journal:  Virus Genes       Date:  2013-01-10       Impact factor: 2.332

7.  The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain.

Authors:  Aidin Molouki; Yi-Te Hsu; Fatemeh Jahanshiri; Syahril Abdullah; Rozita Rosli; Khatijah Yusoff
Journal:  Virol J       Date:  2011-08-03       Impact factor: 4.099

8.  A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells.

Authors:  Mohamed Rajik; Abdul Rahman Omar; Aini Ideris; Sharifah Syed Hassan; Khatijah Yusoff
Journal:  Int J Biol Sci       Date:  2009-08-08       Impact factor: 6.580

Review 9.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

10.  Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases.

Authors:  Vinay Ganeshrao Joshi; Vikas D Dighe; Dimpal Thakuria; Yashpal Singh Malik; Satish Kumar
Journal:  Indian J Virol       Date:  2013-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.